Actavalon Company
Actavalon is an oncology-focused company targeting two fundamental cancer pathways – the p53 tumor suppressor pathway and the Aryl Hydrocarbon Receptor (AhR) pathway.
Technology:
Preventive Medicine
Industry:
Precision Medicine
Headquarters:
Corona Del Mar
Founded Date:
2013
Employees Number:
Undisclosed
Funding Status:
undisclosed
Register and Claim Ownership